Infused cell doses and unit dominance
| Infused cell dose . | Median cell dose (range) . | P . | |
|---|---|---|---|
| Dominant unit, n = 79 . | Nondominant unit, n = 79 . | ||
| TNC × 107/kg | 2.1 (1.2-11.3) | 2.3 (0.9-7.3) | .64 |
| CD34+ × 105/kg | 0.9 (0.1-4.1) | 0.8 (0.2-6.4) | .50 |
| CD3+ × 106/kg | 3.9 (0.8-10.6) | 3.3 (0.3-12.0) | .04 |
| CFU × 104/kg | 3.3 (0.2-14.7) | 2.8 (0.2-15.8) | .57 |
| Infused cell dose . | Median cell dose (range) . | P . | |
|---|---|---|---|
| Dominant unit, n = 79 . | Nondominant unit, n = 79 . | ||
| TNC × 107/kg | 2.1 (1.2-11.3) | 2.3 (0.9-7.3) | .64 |
| CD34+ × 105/kg | 0.9 (0.1-4.1) | 0.8 (0.2-6.4) | .50 |
| CD3+ × 106/kg | 3.9 (0.8-10.6) | 3.3 (0.3-12.0) | .04 |
| CFU × 104/kg | 3.3 (0.2-14.7) | 2.8 (0.2-15.8) | .57 |
Infused cell doses and unit dominance in 79 double-unit CB transplant recipients with engraftment are shown. Dominant units had a higher CD3+ cell dose.